Lea Didion didn’t realize the night sweats she began experiencing in her 40s might be a sign of perimenopause. Her doctor ...

Alma reports on perimenopause symptoms for women over 35, emphasizing fluctuating hormones, mood changes, and the need for ...

Transdermal estradiol patches and LHRH agonists led to similar metastasis-free and overall survival in locally advanced prostate cancer. Estradiol was associated with substantially lower incidence of ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver hormone therapy, according to the results of a large clinical trial led by UCL ...

Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...

If you’re having a hard time getting your estrogen patch prescription filled, you’re not alone. In some parts of the country, ...

SPOKANE, Wash. — Menopausal women who rely on hormone patches for symptom relief are facing supply shortages as pharmacies struggle to keep up with increasing demand for the popular treatment method.

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver hormone therapy, according to the results of a large clinical trial led by UCL ...

A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as effectively as standard hormone injections in men with locally advanced or ...

Transdermal estradiol for locally advanced prostate cancer matched luteinizing hormone-releasing hormone (LHRH) agonists as androgen deprivation therapy (ADT) for reducing distant metastasis, and with ...

The FDA's recent removal of black box warnings on hormone therapy products triggered a prescription surge and supply shortage. All five patch manufacturers are running at full capacity but still ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver hormone therapy, according to the results of a large clinical trial led by UCL ...